Sharron A.N. Brown

1.6k total citations
18 papers, 1.4k citations indexed

About

Sharron A.N. Brown is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Sharron A.N. Brown has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Sharron A.N. Brown's work include NF-κB Signaling Pathways (10 papers), interferon and immune responses (6 papers) and Cell death mechanisms and regulation (5 papers). Sharron A.N. Brown is often cited by papers focused on NF-κB Signaling Pathways (10 papers), interferon and immune responses (6 papers) and Cell death mechanisms and regulation (5 papers). Sharron A.N. Brown collaborates with scholars based in United States, Japan and Switzerland. Sharron A.N. Brown's co-authors include Jeffrey A. Winkles, Heather N. Hanscom, Sheau-Line Feng, Patrick J. Donohue, Hong Vu, Robert Friesel, Arundhati Ghosh, Mark S. Williams, Gregory F. Alberts and Daniel A. Lawrence and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Sharron A.N. Brown

18 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sharron A.N. Brown

Since Specialization

Citations

This map shows the geographic impact of Sharron A.N. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharron A.N. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharron A.N. Brown more than expected).

Fields of papers citing papers by Sharron A.N. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharron A.N. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharron A.N. Brown. The network helps show where Sharron A.N. Brown may publish in the future.

Co-authorship network of co-authors of Sharron A.N. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Sharron A.N. Brown. A scholar is included among the top collaborators of Sharron A.N. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharron A.N. Brown. Sharron A.N. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion 2016 ·Oncotarget ·Cheryl Armstrong, Rebeca Galisteo, Sharron A.N. Brown, Jeffrey A. Winkles	24
2	TWEAK-Independent Fn14 Self-Association and NF-κB Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain 2013 ·PLoS ONE ·Sharron A.N. Brown, Emily H. Cheng, Mark S. Williams, Jeffrey A. Winkles	35
3	The HER2- and Heregulin β1 (HRG)–Inducible TNFR Superfamily Member Fn14 Promotes HRG-Driven Breast Cancer Cell Migration, Invasion, and MMP9 Expression 2013 ·Molecular Cancer Research ·Kaushal Asrani, Ruth A. Keri, Rebeca Galisteo, Sharron A.N. Brown, Sarah J. Morgan, Arundhati Ghosh, Nhan L. Tran, Jeffrey A. Winkles	36
4	The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment 2012 ·Journal of Investigative Dermatology ·Hong Zhou, Sühendan Ekmekçioglu, John W. Marks, Khalid A. Mohamedali, Kaushal Asrani, (unknown), Sharron A.N. Brown, Emily H. Cheng, Michele B. Weiss, Walter N. Hittelman, Nhan L. Tran, Hideo Yagita∥, Jeffrey A. Winkles, Michael G. Rosenblum	47
5	Full-length, Membrane-anchored TWEAK Can Function as a Juxtacrine Signaling Molecule and Activate the NF-κB Pathway 2010 ·Journal of Biological Chemistry ·Sharron A.N. Brown, Arundhati Ghosh, Jeffrey A. Winkles	65
6	The Fibroblast Growth Factor–Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity 2008 ·Molecular Cancer Research ·Amanda L. Willis, Nhan L. Tran, (unknown), Nichole Charlton, Hong Vu, Sharron A.N. Brown, Michael A. Black, Wendy S. McDonough, Shannon P. Fortin Ensign, Joshua R. Niska, Jeffrey A. Winkles, Heather E. Cunliffe	73
7	Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1α under Hypoxic Conditions 2008 ·Cancer Research ·Yali Yang, Jingxiang Bai, Rulong Shen, Sharron A.N. Brown, Elena V. Komissarova, Ying Huang, Ning Jiang, Gregory F. Alberts, Max Costa, Lu Luo, Jeffrey A. Winkles, Wei Dai	99
8	TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration 2006 ·The EMBO Journal ·Mahasweta Girgenrath, (unknown), Christine A. Kostek, Beth Browning, Monica Wang, Sharron A.N. Brown, Jeffrey A. Winkles, Jennifer S. Michaelson, Norm Allaire, Pascal Schneider, Martin Scott, Yen‐Ming Hsu, Hideo Yagita∥, Richard A. Flavell, Jeffrey B. Miller, Linda C. Burkly, Timothy S. Zheng	184
9	TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules 2006 ·Biochemical Journal ·Sharron A.N. Brown, Heather N. Hanscom, Hong Vu, Shelesa A. Brew, Jeffrey A. Winkles	46
10	A Soluble Fn14-Fc Decoy Receptor Reduces Infarct Volume in a Murine Model of Cerebral Ischemia 2005 ·American Journal Of Pathology ·Manuel Yepes, Sharron A.N. Brown, Elizabeth Moore, Elizabeth Smith, Daniel A. Lawrence, Jeffrey A. Winkles	110
11	Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Overexpression in HEK293 Cells Promotes Tumor Growth and Angiogenesis in Athymic Nude Mice 2004 ·Cancer Research ·David H. Ho, Hong Vu, Sharron A.N. Brown, Patrick J. Donohue, Heather N. Hanscom, Jeffrey A. Winkles	80
12	Progressive Ankylosis (Ank) Protein Is Expressed by Neurons and Ank Immunohistochemical Reactivity Is Increased by Limbic Seizures 2003 ·Laboratory Investigation ·Manuel Yepes, Elizabeth Moore, Sharron A.N. Brown, Heather N. Hanscom, Elizabeth Smith, Daniel A. Lawrence, Jeffrey A. Winkles	23
13	TWEAK Is an Endothelial Cell Growth and Chemotactic Factor That Also Potentiates FGF-2 and VEGF-A Mitogenic Activity 2003 ·Arteriosclerosis Thrombosis and Vascular Biology ·Patrick J. Donohue, (unknown), Sharron A.N. Brown, Heather N. Hanscom, John Buschman, Shobha Thangada, Timothy Hla, Mark S. Williams, Jeffrey A. Winkles	144
14	The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation 2003 ·Biochemical Journal ·Sharron A.N. Brown, (unknown), Heather N. Hanscom, Sheau-Line Feng, Jeffrey A. Winkles	154
15	The Mitogen-inducible Fn14 Gene Encodes a Type I Transmembrane Protein that Modulates Fibroblast Adhesion and Migration 1999 ·Journal of Biological Chemistry ·(unknown), Debbie K.W. Hsu, Yan Guo, Sharron A.N. Brown, (unknown), Kimberly A. Peifley, Gregory F. Alberts, Neal G. Copeland, Debra J. Gilbert, Nancy A. Jenkins, (unknown), Jeffrey A. Winkles	179
16	Production of Recombinant Xenopus Fibroblast Growth Factor Receptor-1 Using a Baculovirus Expression System 1993 ·Biochemical and Biophysical Research Communications ·Sharron A.N. Brown, Robert Friesel	6
17	Acute graft-versus-host-like disease induced by human CD56+, CD16+, CD8-dim+ cells in SCID mice. 1993 ·PubMed ·(unknown), James Thompson, Sharron A.N. Brown, C. Darrell Jennings, P. Jean Henslee‐Downey	7
18	Spatially restricted expression of fibroblast growth factor receptor-2 during Xenopus development 1992 ·Development ·Robert Friesel, Sharron A.N. Brown	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact